3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
4
Unknown
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
24
Colorectal Neoplasms
19
Stomach Neoplasms
15
Rectal Neoplasms
13
Triple Negative Breast Neoplasms
10
Pancreatic Neoplasms
7
Neoplasm Metastasis
7
Nasopharyngeal Carcinoma
6
Colonic Neoplasms
6
Neoplasms
4
Gallbladder Neoplasms
4
Cholangiocarcinoma
4
Anus Neoplasms
4
Adenocarcinoma Of Esophagus
4
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Somatostatinoma
2
Recurrence
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Klatskin Tumor
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Cancer Metastatic
2
Clinical Stage I Gastric Cancer AJCC v8
2
Biliary Tract Neoplasms
2
Adenoma, Islet Cell
2
Squamous Cell Carcinoma of Head and Neck
1
Spinocerebellar Degenerations
1
Solid Cancer
1
Skin Neoplasms
1
Rectal Diseases
1
Interventions
pembrolizumab
2
Gemcitabine
2
Cisplatin
2
Bevacizumab
2
penpulimab
1
atezolizumab
1
Vitamin D
1
Tablets
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Immunoglobulin G
1
Fluorouracil
1
Disulfides
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Nasopharyngeal Neoplasms
×
Capecitabine
×
Clear all
NCT05807880
2026-01-23
ALTER-HN005
Sun Yat-sen University
Phase 2
Active not recruiting
59 enrolled